Skip to content

Relay Therapeutics, Inc. RLAY Prepaid & Other Current

Prepaid & Other Current at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$59.83M+87.5%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$18.35M+19.4%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$11.43M+58.2%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$12.49M+60.6%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$22.49M+354%
Revvity logo
RevvityRVTY
$189.11M+4.1%

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s prepaid & other current?
Relay Therapeutics, Inc. (RLAY) reported prepaid & other current of $11.84M in Q1 2026.
How has Relay Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Relay Therapeutics, Inc.'s prepaid & other current decreased by 46.1% year-over-year, from $21.95M to $11.84M.
What is the long-term trend for Relay Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s prepaid & other current has grown at a 13.6% compound annual growth rate (CAGR), from $9.39M to $17.79M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.